Theravance Biopharma, Inc. (TBPH)

16.44 +0.19 (+1.17%) USD  |  NASDAQ  |  May 20, 09:48
More

Theravance Biopharma Total Operating Expenses (Quarterly)

Total Operating Expenses (Quarterly) Chart

View Total Operating Expenses (Quarterly) for TBPH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Operating Expenses (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Operating Expenses (Quarterly) Range, Past 5 Years

View Total Operating Expenses (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Operating Expenses (Quarterly) Benchmarks

View Total Operating Expenses (Quarterly) Benchmarks
Start Trial
Viatris, Inc. Upgrade
Relmada Therapeutics, Inc. Upgrade
Indivior Pharmaceuticals, Inc. Upgrade
Corcept Therapeutics, Inc. Upgrade
Assertio Holdings, Inc. Upgrade